Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 14, 284-288, May 1, 1954]
© 1954 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nungester, W. J.
Right arrow Articles by Fisher, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nungester, W. J.
Right arrow Articles by Fisher, H.

The Inactivation in Vivo of Mouse Lymphosarcoma 6C3HED by Antibodies Produced in a Foreign Host Species*

W. J. Nungester and Helen Fisher

( Dept. of Bacteriology, University of Michigan, Ann Arbor, Michigan)

From the results of these experiments, evidence is provided that antibodies can be produced in a foreign host species against a tissue fraction isolated from mouse lymphosarcoma 6C3HED. When this antiserum was used for the in vivo inactivation of the neoplasm, tumors developed in only 18.0 per cent of the sites inoculated with tumor. The injection of tumor-implanted mice with normal rabbit serum resulted in tumor takes in 96.9 per cent of the sites. Attempts to inactivate the tumor with antisera against various mouse tissue pellet fractions resulted in considerably less protection than when the specific antitumor serum was used. Rabbit antisera against a tumor pellet fraction isolated from rat carcinoma tissue were also ineffective (90.4 per cent tumor takes) in protecting mice against tumor development. When the administration of antitumor serum was delayed until 96 hours after tumor implantation or when the antitumor serum was diluted 1:16, no protection was noted.

* Aided by grants from the Damon Runyon Foundation and the Atomic Energy Commission.

Received 10/22/53.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1954 by the American Association for Cancer Research.